Chimerix, Inc. (CMRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:32PM EDT. Market open.
| Previous close | 0.9630 |
| Open | 0.9550 |
| Bid | 0.9381 x 200 |
| Ask | 0.9644 x 100 |
| Day's range | 0.9301 - 0.9700 |
| 52-week range | 0.8800 - 1.5700 |
| Volume | |
| Avg. volume | 343,322 |
| Market cap | 85.148M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9400 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyChimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript May 1, 2024 Chimerix, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.21. Chimerix, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, […]
- GuruFocus.com
Chimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
Insights into Chimerix Inc's financial health, strategic progress in clinical trials, and future plans from the latest earnings call.
© 2024 Yahoo. All rights reserved.